{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:06:02Z","timestamp":1778238362930,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["APQ-408675\/2018-7"],"award-info":[{"award-number":["APQ-408675\/2018-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R005850\/1"],"award-info":[{"award-number":["MR\/R005850\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00436-020-06971-2","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T05:05:24Z","timestamp":1605503124000},"page":"321-335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis"],"prefix":"10.1007","volume":"120","author":[{"given":"Camila S.","family":"Freitas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o A.","family":"Oliveira-da-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela P.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafaella R.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora V. C.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago A. R.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana M. R.","family":"Antinarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda S.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grasiele S. V.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicio T. S.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rory C. F.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Ludolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela S.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Munkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flaviano M.","family":"Ottoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla R. V.","family":"Campana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria V.","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine S.","family":"Coimbra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fern\u00e3o C.","family":"Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo M.","family":"P\u00e1dua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-9014","authenticated-orcid":false,"given":"Eduardo A. F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"key":"6971_CR1","doi-asserted-by":"crossref","first-page":"e0004468","DOI":"10.1371\/journal.pntd.0004468","volume":"10","author":"E Adem","year":"2016","unstructured":"Adem E, Tajebe F, Getahun M, Kiflie A, Diro E, Hailu A, Shkedy Z, Mengesha B, Mulaw T, Atnafu S, Deressa T, Mathewos B, Abate E, Modolell M, Munder M, M\u00fcller I, Takele Y, Kropf P (2016) Successful treatment of human visceral leishmaniasis restores antigen specific IFN-\u03b3, but not IL-10 production. PLoS Negl Trop Dis 10:e0004468","journal-title":"PLoS Negl Trop Dis"},{"key":"6971_CR2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2741\/4629","volume":"23","author":"VV Andrade-Neto","year":"2018","unstructured":"Andrade-Neto VV, Cunha-Junior EF, Faioes VS, Pereira TM, Silva RL, Leon LL, Torres-Santos EC (2018) Leishmaniasis treatment: update of possibilities for drug repurposing. Front Biosci 23:967\u2013996","journal-title":"Front Biosci"},{"key":"6971_CR3","doi-asserted-by":"publisher","unstructured":"Antonia AL, Wang L, Ko DC (2018) A real-time PCR assay for quantification of parasite burden in murine models of leishmaniasis 6:e5905. https:\/\/doi.org\/10.7717\/peerj.5905","DOI":"10.7717\/peerj.5905"},{"key":"6971_CR4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/1742-6723.12873","volume":"30","author":"H Arbabian","year":"2018","unstructured":"Arbabian H, Lee HM, Graudins A (2018) Elderly patients with suspected chronic digoxin toxicity: a comparison of clinical characteristics of patients receiving and not receiving digoxin-Fab. Emerg Med Australas 30:242\u2013248","journal-title":"Emerg Med Australas"},{"key":"6971_CR5","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.ajem.2017.05.040","volume":"35","author":"M Biteker","year":"2017","unstructured":"Biteker M, \u00d6zlek B, \u00d6zlek E, Biteker FS, Ba\u015faran N, \u00c7eki\u00e7 EG (2017) Digoxin use in atrial fibrillation. Am J Emerg Med 35:1196","journal-title":"Am J Emerg Med"},{"key":"6971_CR6","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.2147\/IJN.S140363","volume":"12","author":"N Bruni","year":"2017","unstructured":"Bruni N, Stella B, Giraudo L, Pepa CD, Gastaldi D, Dosio F (2017) Nanostructured delivery systems with improved leishmanicidal activity: a critical review. Int J Nanomedicine 12:5289\u20135311","journal-title":"Int J Nanomedicine"},{"key":"6971_CR7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M (2018) Leishmaniasis. Lancet 392:951\u2013970","journal-title":"Lancet"},{"key":"6971_CR8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5694\/j.1326-5377.2003.tb05445.x","volume":"179","author":"TJ Campbell","year":"2003","unstructured":"Campbell TJ, Mc Donald PS (2003) Digoxin in heart failure and cardiac arrhythmias. Med J Aust 179:98\u2013102","journal-title":"Med J Aust"},{"key":"6971_CR9","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/14656566.2019.1609940","volume":"20","author":"J Chakravarty","year":"2019","unstructured":"Chakravarty J, Sundar S (2019) Current and emerging medications for the treatment of leishmaniasis. Expert Opin Pharmacother 20:1251\u20131265","journal-title":"Expert Opin Pharmacother"},{"key":"6971_CR10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S2095-4964(16)60261-3","volume":"14","author":"EW Chan","year":"2016","unstructured":"Chan EW, Wong SK, Chan HT (2016) Apocynaceae species with antiproliferative and\/or antiplasmodial properties: a review of ten genera. J Integr Med 14:269\u2013284","journal-title":"J Integr Med"},{"key":"6971_CR11","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","volume":"71","author":"EAF Coelho","year":"2003","unstructured":"Coelho EAF, Tavares CA, Carvalho FA, Chaves KF, Teixeira KN, Rodrigues RC, Charest H, Matlashewski G, Gazzinelli RT, Fernandes AP (2003) Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infect Immun 71:3988\u20133994","journal-title":"Infect Immun"},{"key":"6971_CR12","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1128\/CVI.00338-14","volume":"21","author":"N Craft","year":"2014","unstructured":"Craft N, Birnbaum R, Quanquin N, Erfe MC, Quant C, Haskell J, Bruhn KW (2014) Topical resiquimod protects against visceral infection with Leishmania infantum chagasi in mice. Clin Vaccine Immunol 21:1314\u20131322","journal-title":"Clin Vaccine Immunol"},{"key":"6971_CR13","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2019.00670","volume":"10","author":"A Dayakar","year":"2019","unstructured":"Dayakar A, Chandrasekaran S, Kuchipudi SV, Kalangi SK (2019) Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy. Front Immunol 10:670","journal-title":"Front Immunol"},{"key":"6971_CR14","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","volume":"67","author":"TP Dorlo","year":"2012","unstructured":"Dorlo TP, Balasegaran M, Beijnen JH, Vries PJ (2012) Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J Antimicrob Chemother 67:2576\u20132597","journal-title":"J Antimicrob Chemother"},{"key":"6971_CR15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.parint.2016.07.005","volume":"65","author":"MC Duarte","year":"2016","unstructured":"Duarte MC, Lage LM, Lage DP, Martins VT, Carvalho AM, Roatt BM, Menezes-Souza D, Tavares CA, Alves RJ, Barichello JM, Coelho EA (2016) Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system. Parasitol Int 65:728\u2013736","journal-title":"Parasitol Int"},{"key":"6971_CR16","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.phymed.2012.09.002","volume":"19","author":"SY Eid","year":"2012","unstructured":"Eid SY, El-Readi MZ, Wink M (2012) Digitonin synergistically enhances the cytotoxicity of plant secondary metabolites in cancer cells. Phytomedicine 19:1307\u20131314","journal-title":"Phytomedicine"},{"key":"6971_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/17482940902883246","volume":"11","author":"M Gheorghiade","year":"2009","unstructured":"Gheorghiade M, Harinstein ME, Filippatos GS (2009) Digoxin for the treatment of chronic and acute heart failure syndromes. Acute Card Care 11:83\u201387","journal-title":"Acute Card Care"},{"key":"6971_CR18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/CMR.6.3.230","volume":"6","author":"G Grimaldi Jr","year":"1993","unstructured":"Grimaldi G Jr, Tesh RB (1993) Leishmaniases of the New World: current concepts and implications for future research. Clin Microbiol Rev 6:230\u2013250","journal-title":"Clin Microbiol Rev"},{"key":"6971_CR19","first-page":"5104","volume":"23","author":"E Gurel","year":"2017","unstructured":"Gurel E, Karvar S, Yucesan B, Eker I, Sameeullah M (2017) An overview of cardenolides in digitalis - more than a cardiotonic compound. Curr Pharm Des 23:5104\u20135114","journal-title":"Curr Pharm Des"},{"key":"6971_CR20","first-page":"357","volume":"4","author":"PJ Hauptman","year":"2016","unstructured":"Hauptman PJ, Blume SW, Lewis EF, Ward SJACC (2016) Digoxin toxicity and use of digoxin immune Fab: insights from a national hospital database. Heart Fail 4:357\u2013364","journal-title":"Heart Fail"},{"key":"6971_CR21","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","volume":"162","author":"JP Hughes","year":"2011","unstructured":"Hughes JP, Rees SS, Kalindjian SB, Philpott KL (2011) Principles of early drug discovery. Br J Pharmacol 162:1239\u20131249","journal-title":"Br J Pharmacol"},{"key":"6971_CR22","doi-asserted-by":"crossref","first-page":"e0182474","DOI":"10.1371\/journal.pone.0182474","volume":"12","author":"F Jamal","year":"2017","unstructured":"Jamal F, Shivam P, Kumari S, Singh MK, Sardar AH, Pushpanjali MS, Narayan S, Gupta AK, Pandey K, Das VNR, Ali V, Bimal S, Das P, Singh SK (2017) Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis. PLoS One 12:e0182474","journal-title":"PLoS One"},{"key":"6971_CR23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.0105-2896.2004.00188.x","volume":"201","author":"PM Kaye","year":"2004","unstructured":"Kaye PM, Svensson M, Ato M, Maroof A, Polley R, Stager S, Zubairi S, Engwerda CR (2004) The immunopathology of experimental visceral leishmaniasis. Immunol Rev 201:239\u2013253","journal-title":"Immunol Rev"},{"key":"6971_CR24","first-page":"1","volume":"30","author":"L Kedzierski","year":"2014","unstructured":"Kedzierski L, Evans KJ (2014) Immune responses during cutaneous and visceral leishmaniasis. Parasitology 30:1\u201319","journal-title":"Parasitology"},{"key":"6971_CR25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00436-017-5713-6","volume":"117","author":"DVC Mendon\u00e7a","year":"2018","unstructured":"Mendon\u00e7a DVC, Lage DP, Calixto SL, Ottoni FM, Tavares GSV, Ludolf F, Ch\u00e1vez-Fumagalli MA, Schneider MS, Duarte MC, Tavares CAP, Alves RJ, Coimbra ES, Coelho EAF (2018) Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species. Parasitol Res 117:391\u2013403","journal-title":"Parasitol Res"},{"key":"6971_CR26","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.biopha.2018.10.143","volume":"109","author":"DVC Mendon\u00e7a","year":"2019","unstructured":"Mendon\u00e7a DVC, Tavares GSV, Lage DP, Soyer TG, Carvalho LM, Dias DS, Ribeiro PAF, Ottoni FM, Antinarelli LMR, Vale DL, Ludolf F, Duarte MC, Coimbra ES, Ch\u00e1vez-Fumagalli MA, Roatt BM, Menezes-Souza D, Barichello JM, Alves RJ, Coelho EAF (2019) In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic\u00ae F127-based polymeric micelle system against Leishmania amazonensis infection. Biom Pharmacol 109:779\u2013787","journal-title":"Biom Pharmacol"},{"key":"6971_CR27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0032-1328243","volume":"79","author":"T Mijatovic","year":"2013","unstructured":"Mijatovic T, Kiss R (2013) Cardiotonic steroids-mediated Na+\/K+-ATPase targeting could circumvent various chemoresistance pathways. Planta Med 79:189\u2013198","journal-title":"Planta Med"},{"key":"6971_CR28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/QCO.0b013e328359eff2","volume":"25","author":"AH Mohamed-Ahmed","year":"2012","unstructured":"Mohamed-Ahmed AH, Brocchini S, Croft SL (2012) Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis. Curr Opin Infect Dis 25:695\u2013702","journal-title":"Curr Opin Infect Dis"},{"key":"6971_CR29","doi-asserted-by":"crossref","first-page":"065101","DOI":"10.1088\/1361-6528\/28\/6\/065101","volume":"28","author":"LB Oliveira-de-Siqueira","year":"2017","unstructured":"Oliveira-de-Siqueira LB, Cardoso VS, Rodrigues IA, Vazquez-Villa AL, Santos EP, Guimar\u00e3es BCLR, Coutinho CSC, Vermelho AB, Junior ER (2017) Development and evaluation of zinc phthalocyanine nanoemulsions for use in photodynamic therapy for Leishmania spp. Nanotechnology 28:065101","journal-title":"Nanotechnology"},{"key":"6971_CR30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1590\/S0103-50532005000400019","volume":"16","author":"RM P\u00e1dua","year":"2005","unstructured":"P\u00e1dua RM, Oliveira AB, Souza-Filho JD, Vieira GJ, Takahashi JA, Braga FC (2005) Biotransformation of digitoxigenin by Fusarium ciliatum. J Braz Chem Soc 16:614\u2013619","journal-title":"J Braz Chem Soc"},{"key":"6971_CR31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/10799893.2019.1660893","volume":"39","author":"CN Patel","year":"2019","unstructured":"Patel CN, Kumar SP, Modi KM, Soni MN, Modi NR, Pandya H\u00c1 (2019) Cardiotonic steroids as potential Na(+)\/K(+)-ATPase inhibitors - a computational study. J Recept Signal Transduct Res 39:226\u2013234","journal-title":"J Recept Signal Transduct Res"},{"key":"6971_CR32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejmech.2017.08.030","volume":"139","author":"MRC Raja","year":"2017","unstructured":"Raja MRC, Velappan AB, Chellappan D, Debnath J, Kar Mahapatra S (2017) Eugenol derived immunomodulatory molecules against visceral leishmaniasis. Eur J Med Chem 139:503\u2013518","journal-title":"Eur J Med Chem"},{"key":"6971_CR33","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","volume":"56","author":"S Rijal","year":"2013","unstructured":"Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, Dorlo T, Beijnen JH, Vanaerschot M, Decuypere S, Dhakal SS, Das ML, Karki P, Singh R, Boelaert M, Dujardin JC (2013) Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clin Infect Dis 56:1530\u20131538","journal-title":"Clin Infect Dis"},{"key":"6971_CR34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/0972-9062.179209","volume":"53","author":"H Sakkas","year":"2016","unstructured":"Sakkas H, Gartzonika C, Levidiotou S (2016) Laboratory diagnosis of human visceral leishmaniasis. J Vector Borne Dis 53:8\u201316","journal-title":"J Vector Borne Dis"},{"key":"6971_CR35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/0897190016642361","volume":"30","author":"MJ Scalese","year":"2017","unstructured":"Scalese MJ, Salvatore DJ (2017) Role of digoxin in atrial fibrillation. J Pharm Pract 30:434\u2013440","journal-title":"J Pharm Pract"},{"key":"6971_CR36","doi-asserted-by":"crossref","first-page":"e1874","DOI":"10.1371\/journal.pntd.0001874","volume":"6","author":"OP Singh","year":"2012","unstructured":"Singh OP, Stober CB, Singh AK, Blackwell JM, Sundar S (2012) Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis. PLoS Negl Trop Dis 6:e1874","journal-title":"PLoS Negl Trop Dis"},{"key":"6971_CR37","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.ijbiomac.2017.07.161","volume":"105","author":"PK Singh","year":"2017","unstructured":"Singh PK, Pawar VK, Jaiswal AK, Singh Y, Srikanth CH, Chaurasia M, Bora HK, Raval K, Meher JG, Gayen JR, Dube A, Chourasia MK (2017) Chitosan coated Pluronic F127 micelles for effective delivery of amphotericin B in experimental visceral leishmaniasis. Int J Biol Macromol 105:1220\u20131231","journal-title":"Int J Biol Macromol"},{"key":"6971_CR38","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s10637-013-9984-1","volume":"31","author":"M Slingerland","year":"2013","unstructured":"Slingerland M, Cerella C, Guchelaar HJ, Diederich M, Gelderblom H (2013) Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials. Investig New Drugs 31:1087\u20131094","journal-title":"Investig New Drugs"},{"key":"6971_CR39","doi-asserted-by":"crossref","first-page":"101966","DOI":"10.1016\/j.parint.2019.101966","volume":"73","author":"JKT Sousa","year":"2019","unstructured":"Sousa JKT, Antinarelli LMR, Mendon\u00e7a DVC, Lage DP, Tavares GSV, Dias DS, Ribeiro PAF, Ludolf F, Coelho VTS, Oliveira-da-Silva JA, Perin L, Oliveira BA, Alvarenga DF, Ch\u00e1vez-Fumagalli MA, Brand\u00e3o GC, Nobre V, Pereira GR, Coimbra ES, Coelho EAF (2019) A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis. Parasitol Int 73:101966","journal-title":"Parasitol Int"},{"key":"6971_CR40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13071-017-1969-z","volume":"10","author":"S Srivastava","year":"2017","unstructured":"Srivastava S, Mishra J, Gupta AK, Singh A, Shankar P, Singh S (2017) Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India. Parasit Vectors 10:49","journal-title":"Parasit Vectors"},{"key":"6971_CR41","doi-asserted-by":"crossref","unstructured":"Su LJ, Zhang JH, Gomez H, Murugan R, Hong X, Xu D, Jiang F, Peng ZY (2019) Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxidative Med Cell Longev 2019:5080843","DOI":"10.1155\/2019\/5080843"},{"key":"6971_CR42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1517\/13543784.2014.954035","volume":"24","author":"S Sundar","year":"2015","unstructured":"Sundar S, Chakravarty J (2015) Investigational drugs for visceral leishmaniasis. Expert Opin Investig Drugs 24:43\u201359","journal-title":"Expert Opin Investig Drugs"},{"key":"6971_CR43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1017\/S0031182017002116","volume":"145","author":"S Sundar","year":"2018","unstructured":"Sundar S, Singh A (2018) Chemotherapeutics of visceral leishmaniasis: present and future developments. Parasitology 145:481\u2013489","journal-title":"Parasitology"},{"key":"6971_CR44","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4269\/ajtmh.19-0179","volume":"101","author":"S Sundar","year":"2019","unstructured":"Sundar S, Singh A, Agrawal N, Chakravarty J (2019) Effectiveness of single-dose liposomal amphotericin B in visceral leishmaniasis in Bihar. Am J Trop Med Hyg 101:795\u2013798","journal-title":"Am J Trop Med Hyg"},{"key":"6971_CR45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/bcpt.12990","volume":"123","author":"GSV Tavares","year":"2018","unstructured":"Tavares GSV, Mendon\u00e7a DVC, Lage DP, Granato JDT, Ottoni FM, Ludolf F, Ch\u00e1vez-Fumagalli MA, Duarte MC, Tavares CAP, Alves RJ, Coimbra ES, Coelho EAF (2018) Antileishmanial activity, cytotoxicity and mechanism of action of clioquinol against Leishmania infantum and Leishmania amazonensis species. Basic Clin Pharmacol Toxicol 123:236\u2013246","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"6971_CR46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1051\/parasite\/2020027","volume":"27","author":"GSV Tavares","year":"2020","unstructured":"Tavares GSV, Mendon\u00e7a DVC, Pereira IAG, Oliveira-da-Silva JA, Ramos FF, Lage DP, Machado AS, Carvalho LM, Reis TAR, Perin L, Carvalho AMRS, Ottoni FM, Ludolf F, Freitas CS, Bandeira RS, Silva AM, Ch\u00e1vez-Fumagalli MA, Duarte MC, Menezes-Souza D, Alves RJ, Roatt BM, Coelho EAF (2020) A clioquinol-containing Pluronic\u00ae F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model. Parasite 27:29","journal-title":"Parasite"},{"key":"6971_CR47","doi-asserted-by":"crossref","first-page":"455102","DOI":"10.1088\/1361-6528\/ab373e","volume":"30","author":"IV Valle","year":"2019","unstructured":"Valle IV, Machado ME, Ara\u00fajo CDCB, Cunha-Junior EF, Pacheco JS, Torres-Santos EC, Silva LCRP, Cabral LM, Carmo FA, Sathler PC (2019) Oral pentamidine-loaded poly(d,l-lactic-co-glycolic) acid nanoparticles: an alternative approach for leishmaniasis treatment. Nanotechnology. 30:455102","journal-title":"Nanotechnology."},{"key":"6971_CR48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.idc.2018.10.005","volume":"33","author":"J Van Griensven","year":"2019","unstructured":"Van Griensven J, Diro E (2019) Visceral leishmaniasis: recent advances in diagnostics and treatment regimens. Infect Dis Clin N Am 33:79\u201399","journal-title":"Infect Dis Clin N Am"},{"key":"6971_CR49","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.2174\/1381612825666190621154552","volume":"25","author":"V Wagner","year":"2019","unstructured":"Wagner V, Minguez-Menendez A, Pena J, Fern\u00e1ndez-Prada C (2019) Innovative solutions for the control of leishmaniases: nanoscale drug delivery systems. Curr Pharm Des 25:1582\u20131592","journal-title":"Curr Pharm Des"},{"key":"6971_CR50","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.2147\/IJN.S106548","volume":"12","author":"MY Want","year":"2017","unstructured":"Want MY, Islammudin M, Chouhan G, Ozbak HA, Hemeg HA, Chattopadhyay AP, Afrin F (2017) Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis. Int J Nanomedicine 12:2189\u20132204","journal-title":"Int J Nanomedicine"},{"key":"6971_CR51","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40256-018-0292-1","volume":"18","author":"TF Whayne Jr","year":"2018","unstructured":"Whayne TF Jr (2018) Clinical use of digitalis: a state of the art review. Am J Cardiovasc Drugs 18:427\u2013440","journal-title":"Am J Cardiovasc Drugs"},{"key":"6971_CR52","unstructured":"World Health Organization (2018) Leishmaniasis. http:\/\/www.who.int\/topics\/leishmaniasis\/en\/, 2018, Accessed data: 2 June 2018"},{"key":"6971_CR53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/10715762.2017.1331037","volume":"51","author":"J Xu","year":"2017","unstructured":"Xu J, Guo Y, Sui T, Wang Q, Zhang Y, Zhang R, Wang M, Guan S, Wang L (2017) Molecular mechanisms of antioxidant and anti-aging effects induced by convallatoxin in Caenorhabditis elegans. Free Radic Res 51:529\u2013544","journal-title":"Free Radic Res"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-020-06971-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-020-06971-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-020-06971-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T07:28:38Z","timestamp":1744097318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-020-06971-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["6971"],"URL":"https:\/\/doi.org\/10.1007\/s00436-020-06971-2","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,16]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}